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Fine tuning of individual enzyme expression level is necessary to alleviate metabolic imbal-
ances in synthetic heterologous pathways. A known approach consists of choosing a
suitable combination of promoters, based on their characterized strengths in model con-
ditions. We questioned whether each step of a multiple-gene synthetic pathway could be
independently tunable at the transcription level. Three open reading frames, coding for
enzymes involved in a synthetic pathway, were combinatorially associated to different pro-
moters on an episomal plasmid in Saccharomyces cerevisiae. We quantified the mRNA
levels of the three genes in each strain of our generated combinatorial metabolic library.
Our results evidenced that the ORF nature, position, and orientation induce strong discrep-
ancies between the previously reported promoters’ strengths and the observed ones. We
conclude that, in the context of metabolic reconstruction, the strength of usual promoters
can be dramatically affected by many factors. Among them, transcriptional interference
and ORF nature seem to be predominant.
Keywords: metabolic engineering,Saccharomyces cerevisiae, combinatorial metabolic libraries, expression tuning,
plasmid-encoded metabolic pathway
INTRODUCTION
Many biotechnological processes involve microorganisms to pro-
duce molecules of interest in a sustainable way, sometimes com-
peting efficiently with chemical synthesis (Kim et al., 2013). In
this context, one of the typical goals of synthetic biology, and
more particularly of metabolic engineering, is to genetically mod-
ify known and robust microorganisms to create artificial path-
ways compatible with industrial processes. However, unregulated
expression of foreign enzymes used to rebuild synthetic pathways
in heterologous hosts may interfere with endogenous metabolic
fluxes, causing metabolic burden, overconsumption of resources,
or release of toxic intermediates (Glick, 1995; Neubauer et al.,
2003). It is thus necessary to properly adjust the levels of all
enzymes participating in the heterologous metabolic pathway to
maximize metabolic fluxes toward the desired path while avoid-
ing undesirable impacts on cell physiology and viability (Lu and
Jeffries, 2007; Ajikumar et al., 2010; Ramon and Smith, 2011).
Balancing natural versus synthetic fluxes can be achieved by indi-
vidually tuning the expression level of each foreign enzyme. In
the host Saccharomyces cerevisiae, regulated promoters with tun-
able strengths can be used (Da Silva and Srikrishnan, 2012), but
this approach is often limited by the non-linear responses to the
inducer concentration or by the cost of these molecules, prohib-
itive in an industrial context (Siegele and Hu, 1997; Mnaimneh
et al., 2004). Alternatively, collections of natural or engineered
constitutive promoters of various strengths allow fine tuning of
Abbreviations: GGPP, geranylgeranyl pyrophosphate; GFP, green fluorescent pro-
tein; RT-qPCR, reverse transcription quantitative PCR; qPCR, quantitative PCR;
tHMG1, truncated HMG-CoA reductase.
enzyme expression levels (Alper et al., 2005; Lu and Jeffries, 2007;
Du et al., 2012).
The importance of promoter strength and regulation on net
protein output has been extensively reviewed (Da Silva and Srikr-
ishnan, 2012; Blazeck and Alper, 2013). Some studies characterized
constitutive promoters by placing lacZ (Partow et al., 2010) or flu-
orescent protein encoding ORFs as reporters (Sun et al., 2012; Lee
et al., 2013). Lee et al. (2013) characterized a set of S. cerevisiae
constitutive promoters giving a robust control over gene expres-
sion. They used them to build a combinatorial library leading to
violacein production without any knowledge of the optimal com-
bination of individual enzymes levels. However, Karim et al. (2013)
demonstrated that growth rates and plasmid copy number (para-
meters known to impact production efficiency) were influenced by
additional factors, including the origin of replication and selection
marker on episomal plasmids. One can question whether expres-
sion levels measured with model systems consistently reflect the
strengths of the considered promoters, regardless of their direct
genetic environment.
While chromosome integration of genes is the preferred tech-
nique for final, industrial strains, first optimization steps are usu-
ally performed on plasmids (Ro et al., 2006; Steen et al., 2008;
Ukibe et al., 2009; Kocharin et al., 2012). Our goal was to assess
whether the assigned strengths of promoters, when described in
model systems, can be transposable when multiple expression
cassettes are inserted on a single episomal plasmid. We there-
fore used as model a small, heterologous pathway leading to
the synthesis of zeaxanthin, and implemented it in S. cerevisiae.
The heterologous production of carotenoid molecules has pre-
viously been described using S. cerevisiae (Verwaal et al., 2007;
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Ukibe et al., 2009; Sun et al., 2012), demonstrating that rerouting
the endogenous terpene pathway to these heterologous metabo-
lites is feasible (Figure 1). Three heterologous ORFs from differ-
ent carotenoid-producing organisms were used: CRTI (phytoene
desaturase gene), CRTYB (bifunctional phytoene synthase and
lycopene cyclase gene), both fromXanthophyllomyces dendrorhous,
and CRTZ (β-carotene hydroxylase gene) from Pantoea ananatis.
A small metabolic combinatorial library was built using six consti-
tutive promoters that were reported to be strong, medium, or weak
using the fluorescent protein GFP as a reporter (Sun et al., 2012).
mRNA levels of the three abovementioned genes were quantified
in various culture conditions.
MATERIALS AND METHODS
PLASMID CONSTRUCTIONS
GenesCRTI andCRTYB fromX. dendrorhous were amplified from
plasmid YEplac195 YB/I (kindly supplied by Prof. Gerhard Sand-
mann (Verwaal et al., 2007). CRTZ from P. Ananatis (GenBank
accession number D90087) was chemically synthetized (Genecust,
Luxembourg) after S. cerevisiae codon bias optimization using
Gene Designer 2.0 (see Supplementary Material for optimized
sequence). TEF1, PDC1, PGI1, GPD, ENO2, and TEF2 promot-
ers, as well as ADH1, TEF2, and CYC1 terminators were ampli-
fied from genomic DNA of S. cerevisiae. Overlaps of 30 bp were
designed between adjacent fragments and no spacer sequences
were added between the different transcription units (Table S1
in Supplementary Material). PCR products were purified and
further used for overlapping amplification to construct individ-
ual expression cassettes (promoter-ORF-terminator). A last PCR
amplification was performed with primers RECpRS426_F and
RECpRS426_R to extend (40 bp) the recombination segments
between the synthetized fragments and pRS426 (Christianson
et al., 1992). The library of promoter-ORF-terminator associ-
ations was subsequently assembled by Gibson cloning method
(Gibson et al., 2009) in a SacI/XhoI linearized pRS426 (URA3
selection marker) (Gibson Assembly Cloning Kit, NEB, Ipswich,
MA, USA). The whole construction method is detailed in Figure
S1 in Supplementary Material. The combinatorial library is com-
posed of nine plasmids, named pRS426/A to pRS426/I (Table 1).
Empty pRS426 is named H. To avoid recombination event, no
repeated sequence was inserted into the plasmids. That explains
the absence of reuse of the same promoter in each single construct,
and the choice of three different terminators. The catalytic sub-
unit of HMG-CoA reductase gene (tHMG1) was amplified from
genomic DNA of S. cerevisiae, with primers tHMG1_pCM185_F
and tHMG1_pCM185_R (Table S1 in Supplementary Mater-
ial) and inserted in pCM185 (TRP1 selection marker) (Gari
et al., 1997), resulting in pCM185/tHMG1. All constructions were
verified by sequencing.
STRAINS, CULTURE, AND SAMPLING CONDITIONS
The generated vectors were transformed in the S. cerevisiae
CEN.PK 113-7D strain (Mata his3 – 1 leu2-3,112 trp1-289 ura3-
52 MAL2-8c) by the lithium acetate method (Gietz et al., 1992),
giving birth to strains A to I or A+H to I+H, according to the
presence of empty pCM185 or pCM185/tHMG1, respectively.
Recombinant strains were grown on CSM-URA-TRP plates (MP
Biomedicals, Santa Ana, CA, USA) from a glycerol stock at 30°C
FIGURE 1 | Zeaxanthin reconstruction pathway in the host S. cerevisiae from geranylgeranyl pyrophosphate (GGPP). Heterologous steps are colored.
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Table 1 | Order of genes in the different pRS426 derivatives.
Constructs Transcription unit 1 Transcription unit 2 Transcription unit 3
A TEF1p
CRTI ADH1t
PDC1p
CRTYB TEF2t
PGI1p
CRTZ CYC1t
B TEF1p PGI1p PDC1p
C PDC1p TEF1p PGI1p
D PDC1p PGI1p TEF1p
E PGI1p TEF1p PDC1p
F PGI1p PDC1p TEF1p
G GPDp ENO2p TEF2p
H Empty pRS426
I PDC1p CRTZ CYC1t PGI1p CRTI ADH1t TEF1p CRTYB TEF2t
J PGI1p CRTI ADH1t TEF2t CRTYB TEF1p PDC1p CRTZ CYC1t
The strong promoter is shown in pink, medium promoters are in orange, and the weak promoter is in green.
during approximately 3 days. A single colony was then grown in
50 mL of complete synthetic, selective medium (Table S2 in Sup-
plementary Material) at 30°C and 200 rpm during 24 h. 100 mL
of the same medium was further inoculated at a final OD600 of
0.5, in 500 mL shake flasks. Two milliters of samples were drawn
and immediately cooled to 4°C and centrifuged at 3,200 g (4°C).
The cell-containing pellets were washed once with 1 mL of ice cold
ultrapure water, rapidly centrifuged at 4°C, and quenched in liquid
nitrogen before being stored at−80°C for subsequent nucleic acids
extraction. At the end of the 72 h of culture, cells were harvested
by centrifugation (8,200 g, 2 min), washed once with deionized
water, frozen at −80°C, and lyophilized with a CHRIST Alpha 2–
4 LD plus freeze-drier. All culture experiments were performed in
triplicates. For real independency of triplicates, shake-flasks cul-
tures were performed neither simultaneously, nor from the same
inoculum.
NMR IDENTIFICATION AND QUANTIFICATION OF EXTRACELLULAR
COMPOUNDS
Supernatants were filtered over 0.2µm and quenched at −80°C
prior to their use for NMR quantification of extracellular metabo-
lites on the MetaToul platform. 1H-MMR spectra were recorded
on a Bruker Avance II 500.13 MHz instrument, equipped with a
5 mm probe BBI. Supernatant samples (500µL) were mixed with
100µL of a 4 mM 2-(Trimethylsilyl)propionic-2,2,3,3-d4 acid
(TSP-d4) solution in D2O as an internal intensity- and chemical
shift-standard without further sample pretreatment for metabolite
quantification. Measurements were performed with a zgpr pulse
program, at 286 K with eight scans per spectrum and a flip angle
of 30°(d1: 15 s, TD: 128 K ,and presaturation of the 1H2O sig-
nal – O1P: 4,700 ppm). Basic analysis of the acquired spectra and
peak integrations were performed using the Bruker “TopSpin 3.0”
software suit.
RT-qPCR EXPERIMENTS
Frozen cells were mechanically disrupted using a Tissue Lyser
II (Qiagen, Venlo, the Netherlands) during 3 min at a fre-
quency of 30 Hz. Total nucleic acids were extracted using the
GeneJET RNA purification kit (Thermo Scientific, Waltham,
MA, USA). Genomic DNA contamination was eliminated by
an additional DNase treatment performed with the RNase-free
DNase I (Thermo Scientific,Waltham,MA,USA). RNA quality was
assayed on a Bioanalyzer 2100 with the RNA 6000 Nano LabChip
kit (Agilent Technologies, Santa Clara, CA, USA). One microgram
of RNA was reverse-transcribed into cDNA in a 20µL reaction
using the Maxima first strand cDNA synthesis kit (Thermo Scien-
tific, Waltham, MA, USA). Four microliters of a 10-fold dilution
of the previously synthetized cDNA were added to the qPCR Mas-
ter Mix to perform cDNA relative quantification. Quantitative
PCR (qPCR) reactions were performed in triplicates, in 20µL
final volume and in 96-well plates (Bio-Rad, Hercules, CA, USA)
using the Maxima SYBR Green/Fluorescein qPCR Master Mix
(2X) from Thermo Scientific (Waltham, MA, USA), in the MyIQ
real-time PCR system from Bio-Rad. A blank (No Template Con-
trol) was also incorporated in each assay. Primers were designed
using Primer3Plus1, and their specificity was verified using the
PrimerBLAST tool from NCBI2. qPCR primer sequences are given
in Table S3 in Supplementary Material. The PCR efficiency of
each primer pair(Eff) was evaluated by the dilution series method
using a mix of sampled cDNAs as template. The absence of con-
taminant genomic DNA in RNA preparations was verified using
RNA as a template in real-time PCR assays (minus RT control).
The thermocycling program consisted of one hold at 95°C for
10 min, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C.
After completion of these cycles, melting-curve data were col-
lected to verify PCR specificity, contamination, and absence of
primer dimers.
mRNA VARIATION QUANTIFICATION
Biological samples were prepared in independent triplicates, and
qPCR analyses were performed in technical triplicates, bringing to
six the number of analysis performed for each tested condition.
Four internal control genes were used: ALG9, TFC1, UBC6, and
TAF10, chosen on their demonstrated expression stability over
culture conditions (Teste et al., 2009). All data were calculated
using the gene expression module of the BIORAD iQ5 software,
1http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/
2http://www.ncbi.nlm.nih.gov/tools/primer-blast/
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using the 2∆∆Ct method (Livak and Schmittgen, 2001). Presented
data are average of biological triplicates, normalized to the inter-
nal control genes values, with SD. Results were then expressed in
terms of mRNA normalized variations, relative to the appropriate
reference strain for the observed condition (H or H+H). Although
these reference strains do not contain the genes CRTI,CRTYB, and
CRTZ, some non-specific amplification was detectable in reverse
transcription quantitative PCR (RT-qPCR) when the correspond-
ing cDNAs were targeted. Results were normalized by arbitrarily
set at 1 the level of signal observed in the reference strains, and
expressing mRNA levels in the tested conditions in fold changes
relative to the appropriate reference.
pRS426 COPY NUMBER DETERMINATION
Nucleic acids were extracted as described previously. RNA con-
tamination was eliminated by a DNase-free RNase A treatment
(Thermo Scientific, Waltham, MA, USA) at 37°C during 10 min,
followed by 10 min at 45°C and 10 min at 60°C. Standard curve
for plasmid quantification was done as follows: genomic DNA
extracted from a native CEN.PK 113-7D strain and three differ-
ent amounts of pRS426 plasmid were pooled as to mimic 5.3,
10.6, and 15.9 pRS426 copy number per haploid genome. Quan-
tification was performed using URA3 gene. Twenty nanograms of
each mixture was added to the qPCR Master Mix, generating the
standard curve. pRS426 quantification in the various strains was
performed using the same qPCR amplification starting with 20 ng
of extracted DNA (Figure S2 in Supplementary Material).
RESULTS
ZEAXANTHIN PATHWAY LIBRARY GENERATION
We wanted to understand if promoters of reported strengths (Sun
et al., 2012) can be used to impose a precise transcriptional regula-
tion of expression level of genes involved in a synthetic pathway in
yeast. Individual ORFs encoding a synthetic zeaxanthin pathway
were combinatorially placed under the control of yeast constitu-
tive promoters having different strengths: TEF1p (strong), PGI1p
(weak), PDC1p, GPDp, ENO2p, TEF2p (medium), and three inde-
pendent terminators (see Materials and Methods). An in vitro
recombination method was used to quickly and reliably obtain
the various individual constructs (Figure S1 in Supplementary
Material).
The production, in yeast, of mevalonate by HMG-CoA reduc-
tase is known to be rate-limiting for the metabolic flux leading to
sterols (Donald et al., 1997) and carotenoids (Verwaal et al., 2007;
Yan et al., 2012). Therefore, to faithfully reproduce the deregula-
tion strategy, usually applied when producing terpene compounds,
and to potentially visualize an effect of precursor boost on heterol-
ogous genes expression, a gene encoding the catalytic subunit of
HMG-CoA reductase (tHMG1) from S. cerevisiae was cloned on
pCM185 (pCM185/tHMG1).
Seven strains were generated: six upon transformation with
the six plasmids harboring various promoter strengths and one
corresponded to the transformation with the seventh plasmid
harboring medium strengths promoters. The reference strain
was transformed with the empty pRS426. These eight generated
strains (Table 1) were further transformed with pCM185 or
pCM185/tHMG1, leading to 16 different strains named A to H
when transformed with empty pCM185 (named set 1 through-
out the rest of this document) or A+H to H+H when transformed
with pCM185/tHMG1 (named set 2 throughout the rest of this
document).
S. CEREVISIAE STRAINS, CULTURE, AND SAMPLING
We first determined that no significant differences existed between
the growth curves of the zeaxanthin producing strains and the
reference strains (Figure S3 in Supplementary Material). Dur-
ing batch growth on glucose, yeast cells shift from fermentation
to respiration (diauxic shift) after exhausting the primary car-
bon source, causing extensive reprogramming of the transcrip-
tion machinery (Galdieri et al., 2010). GPD, PDC1, PGI1, and
ENO2 genes are involved in both glucose and ethanol assimilation
processes. Consequently, the associated promoters are potentially
sensitive to the cell metabolic state. We analyzed by NMR the
supernatant of the culture medium of the strains A, C, D, and
H (Figure 2). After 15 h of growth, the medium contained glu-
cose as well as ethanol produced by fermentation. Interestingly,
the glucose concentration was slightly lower in strain H than in
any other strain harboring the zeaxanthin pathway, although the
difference between the growth curves measured for strain H com-
pared to the zeaxanthin strain was within error range. However, it
is possible that the reference strain H consumed glucose slightly
faster than any of the zeaxanthin producing strains. On the con-
trary, after 40 h of growth, only ethanol could be found in the
medium. We therefore determined that at 15 h of growth, the
strains were still fermenting glucose (preferred carbon source);
while at 40 h of growth, they had shifted to respiratory conditions
(consuming ethanol). mRNA extraction and quantification were
then performed either in fermentative context (15 h, glucose) or
in respiratory context (40 h, ethanol).
pRS426 COPY NUMBER QUANTIFICATION
Prior to analyze the transcription variation of the combinatorial
metabolic library genes, we investigated whether the copy num-
ber of the pRS426 derivatives changed in the different strains. We
determined that strain H contained approximately 28± 0.1 copies
of the empty pRS426, a regular value for a 2µ based plasmid
(Romanos et al., 1992) (Figure 3). Using strain F as a represen-
tative for all zeaxanthin producing strains, we determined that
the pRS426/F copy number was 2.0± 0.2 copies per cell only.
It has been demonstrated that in case of deleterious gene prod-
ucts, a decrease in the plasmid copy number was observed (Fang
et al., 2011). Zeaxanthin biosynthesis may lead to a certain toxic-
ity, resulting in a positive selection pressure on cells harboring a
reduced number of the pRS426 derivatives. Interestingly, adding
a second, monocopy plasmid (pCM185/tHMG1) in these two
strains (F and H, generating F+H and H+H respectively) promoted
a systematic decrease of the copy number of pRS426 derivatives
(6.0± 0.3 copies for H+H compared to 28± 0.1 for strain H and
about 0.5± 0.3 copy for F+H compared to 2.0± 0.2 copies in
strain F). This suggests a possible interference between the two
plasmids, as already observed in Escherichia coli (Gruber et al.,
2008). As a conclusion, the copy number of pRS426 derivatives was
affected by the zeaxanthin pathway expression and the presence of
pCM185/tHMG1.
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FIGURE 2 | NMR determination of glucose and ethanol concentrations.
Supernatants of strains A, B, C, D, and H were analyzed after 15 h and 40 h
of growth.
FIGURE 3 | Absolute quantification of the copy number of pRS426/F.
Strains F and F+H were compared with pRS426 in reference strains H and
H+H.
EXPRESSION PROFILE OF THE pRS426 MARKER
Given the discrepancies in the copy number of pRS426 derivatives
when tHMG1 or carotenoid genes were expressed, we wanted to
confirm if this variation was reflected in mRNA levels of the URA3
gene present in the pRS426 backbone (Figure S4 in Supplementary
Material). mRNA levels of URA3 in each set of strains (set 1 or set
2) were averaged, and standardized to the levels calculated from
the reference strain H or H+H, respectively (Figure 4). First, the
fairly minor SD showed that the variation of theURA3 mRNA lev-
els was minimal between the different strains. Secondly, the mean
values of mRNA levels were almost constant over the different
conditions (small variations being within error range), but dra-
matically reduced (50–100-folds) in zeaxanthin producing strains,
FIGURE 4 | Average URA3 mRNA level in four conditions. Analyses
were performed on set 2 or set 1 (with or without tHMG1 expression,
respectively), in glucose (blue bars) or ethanol (red bars) metabolism.
Results were normalized with URA3 signal in strain H for strains from set 1,
and with URA3 signal in strain H+H for strains from set 2. Error bars
represent 1 SD.
when compared to the reference. As mentioned earlier, the copy
number of pRS426 derivatives decreased down to approximately
1 in the strains harboring the zeaxanthin pathway compared to
approximately 30 copies in the reference strains. Consequently,
the strong decrease in the URA3 mRNA levels could hardly be
explained by the sole reduction of the copy number of the pRS426
derivatives. The three heterologous genes were placed far away
and downstream the URA3 gene in pRS426 (Figure S4 in Supple-
mentary Material), theoretically limiting possible transcriptional
effects between them. Nonetheless, transcription of CRTI,CRTYB,
andCRTZ may interfere in some way withURA3 promoter activity
either due to some competition between the different promoters
or possible changes in the plasmid DNA structure, hampering
a correct DNA unwinding prior transcription. A regulation of
endogenous ura3-52 gene present in CEN.PK may also take part
in the URA3 mRNA level reduction. Indeed, the addition of a
plasmid containing the URA3 gene may modify transcriptional
regulation of endogenous uracil pathway.
CONTROLS OF PLASMID INTEGRITY AND CELL PHYSIOLOGY
In order to ascertain reproducibility of our quantifications, several
controls experiments were conducted. To ensure that no recom-
bination events occurred between one of the plasmids and S.
cerevisiae genome, or between the two plasmids, we verified their
integrity after transformation and cultivation. Restriction analyses
(Figure S5 in Supplementary Material), performed on extracted
plasmids, demonstrated that the specific bands of pRS426 and
pCM185 derivatives corresponded to normal restriction profiles.
We then verified if the expression of the different pRS426 deriv-
atives could lead to changes in the transcriptional regulation of
some specific genes. mRNA levels of a restricted number of genes
involved in the production of endogenous carotenoids precursors
were evaluated in the 14 engineered strains. BTS1, ERG20, ERG19,
ERG8, ERG12, and HMG1 were chosen as targets because of their
implication in the production of geranylgeranyl pyrophosphate
www.frontiersin.org February 2015 | Volume 3 | Article 21 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Carquet et al. Transcription interference in metabolic pathway
(GGPP), the precursor involved in the first step of the heterologous
biosynthetic pathway (Figure 1). For HMG1 mRNA quantifica-
tion, primers were designed to avoid detection of transcripts from
tHMG1. There was almost no impact of the carotenoid pathway
on the transcriptional response of the six chosen genes when
tHMG1 was not expressed (level changes are within the error
range) (Figure 5A). However, when tHMG1 was expressed, there
was a slight tendency to overexpress the GGPP pathway genes
(Figure 5B). However, this increase is small compared to the tech-
nical error on this experimental design. In any case, the effects were
minor and equivalent between all producing strains (no more than
3× the reference level) compared to non-producing strains H and
H+H. Therefore, the production of zeaxanthin in our conditions
did probably not strongly impact the pool of precursors and no
physiological adaptation was therefore seen at the level of GGPP
pathway regulation.
ABSENCE OF CORRELATION BETWEEN PROMOTERS STRENGTHS AND
mRNA LEVELS
We analyzed the normalized mRNA levels of CRTI, CRTYB, and
CRTZ genes for each strain and in every growth context. We
again emphasize that only the promoter nature (and strength)
in front of each ORF is different in strains from set 1 or set 2, inde-
pendently (Table 1). Surprisingly, Figure 6 highlights one major
profile in these sets of strains that can be described as follows:
CRTI is the most expressed gene, followed by CRTYB and finally
by CRTZ. The general tendency shows lower levels of mRNAs
in set 2 (in accordance with the pRS426 derivatives copy number
decrease when tHMG1was expressed) or in respiratory conditions.
However, in strain G+H, CRTZ mRNA level (in glucose) was not
impacted by tHMG1 and even augmented compared to the one
measured in strain G. Furthermore, in strain G+H, CRTZ mRNA
level was not modified between glucose and ethanol conditions,
unlike CRTI and CRTYB mRNA levels. In construct G, TEF2p,
controlling CRTZ transcription, is the only promoter not to be
involved in glucose or ethanol assimilation. This may be related
to the CRTZ mRNA level stability over culture conditions. This
results in CRTYB, CRTI, and CRTZ mRNA levels variation less
than 15-fold in strain G+H, a feature that is in good accordance
with the expected mRNA levels imposed by the chosen promoters
(medium strength promoters for all three genes) (Sun et al., 2012).
In conclusion, in our experimental conditions, mRNA levels did
not reflect the previously described strengths of promoters (Sun
et al., 2012).
GENE ORIENTATION AND ORDER STRONGLY AFFECT PROMOTERS
STRENGTHS
We tested the hypothesis that the mRNA levels in our system were
dependent on the genes’ position. We designed two new plasmids,
keeping the promoter-ORF-terminator associations of pRS426/E,
but swapping the positions of the three genes (pRS426/I) or
reversing the CRTYB transcription unit orientation (pRS426/J)
(Table 1). Due to very poor transformation efficiency of CEN.PK
with these new plasmids, only strains I+H and J were generated.
Compared to strain E+H, CRTI mRNA level in strain I+H was
decreased by a factor of 10 while the mRNA levels of CRTYB and
CRTZ were constant (Figures 6C,D). This phenomenon was not
FIGURE 5 | Expression profiles of endogenous GGPP pathway genes.
Bars represent the mean value of the different gene expressions in the
strains from set 1 [(A), red and blue bars for glucose or ethanol metabolism,
respectively], or in the strains from set 2 [(B), red and blue bars for glucose
or ethanol metabolism, respectively]. Error bars represent 1 SD.
dependent on culture conditions, as it was true in glucose and in
ethanol metabolisms. A failure of CRTYB transcription termina-
tion may explain the observed diminution of CRTI mRNA level.
Although TEF2t (terminator associated to CRTYB) was not tested
in Curran et al. (2013) study, its efficiency may not be sufficient
to promote the normal release of the entire transcription machin-
ery at the termination site. This phenomenon may hinder the
RNA polymerase fixation at CRTI promoter. Therefore, chang-
ing the CRTI transcription unit position could alter the promoter
strength, demonstrating that the construction structure and more
precisely the relative gene position interfered with its expression
level.
Relative quantifications of mRNA levels in strain J pointed a
strong decrease of CRTI and CRTYB mRNAs (Figures 6A,B). In
this strain, CRTYB mRNA was absent and CRTI mRNA level was
strongly decreased, while the CRTZ mRNA level was lowered only
by a factor of 10. To ascertain that no recombination events could
have modified the plasmid harboring the zeaxanthin pathway, we
verified (restriction and sequence analysis) that all three genes
were still present and correctly ordered on the pRS426/J extracted
from strain J (Figure S5 in Supplementary Material). In pRS426/J,
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FIGURE 6 | Quantitative RT-PCR analysis of mRNA levels of the three
implemented carotenoid genes. (A) mRNA levels in strains A to J, in
glucose metabolism (normalized with strain H); (B) mRNA levels in strains A
to J, in ethanol metabolism (normalized with strain H); (C) mRNA levels in
strains A+H to I+H, in glucose metabolism (normalized with strain H+H);
(D) mRNA levels in strains A+H to I+H, in ethanol metabolism (normalized with
strain H+H). Bar colors are as follows: CRTI, blue; CRTYB, red; and CRTZ,
green. Error bars represent 1 SD. mRNA levels for strain J in glucose
metabolism were done in duplicate and the error bars represent the two
maximum values.
CRTI and CRTYB were in a convergent configuration, potentially
leading to a collision between the two opposite RNA polymerases.
This phenomenon may render difficult their progress toward the
terminator. Furthermore, during the transcriptional process, the
RNA polymerases progress on DNA making positive supercoils
on both strands simultaneously (Liu and Wang, 1987). This may
create a region of hyper-supercoiling that could possibly prevent
further advancement in either direction on the template, leading
to the suppression of the transcriptional processes of CRTI and
CRTYB. Hence, in our experiments, CRTI mRNA level seemed
to be affected by the gene position and orientation while CRTYB
mRNA level was impacted only by the gene orientation.
DISCUSSION
Our series of experiments reveal that the promoter-independent
control of mRNA levels may result from several different mech-
anisms. The ORF nature, via the sequence related variation of
mRNA half-life, may strongly influence the mRNA level. Occur-
rence of cryptic promoters in ORFs (Pedersen et al., 1999)
might also promote or inhibit transcription independently of the
promoter-induced regulation. Gene terminators are also known
to influence mRNA stabilization (Curran et al., 2013; Yamanishi
et al., 2013). Curran et al. (2013) reported that the terminator of
CYC1 gene (CYC1t) was a poor expression enhancing terminator.
Therefore, the use of CYC1t behind CRTZ may explain the low
levels of its corresponding mRNA. Overall, the quasi absence of
correlation between the strengths of the different promoters and
their corresponding mRNA levels strongly suggests that the relative
ORF positions on the plasmid may drive transcription efficiency.
Experiments performed with the I and J strains reveal that CRTYB
ORF nature also imposed a regulation of its transcription, and
that the observed suppression of CRTI and CRTYB transcription
in strain J was probably due to poor terminator (TEF2t) efficiency.
As CRTZ mRNA level was the most stable over the different tested
conditions, its ORF nature or associated terminator (CYC1t), or
both, seemed to impose a strong transcriptional regulation.
Parts of the effects seen in these two last constructions might
also be attributed to transcription interference (TI). TI is defined as
the suppressive influence of one transcriptional process, directly
and in cis, on a second transcriptional process (Shearwin et al.,
2005). This phenomenon was well-studied with native S. cere-
visiae genes (Prescott and Proudfoot, 2002; Wang et al., 2014) but
only two studies addressed the case of TI in heterologous expres-
sion, demonstrating transcription inhibition effects only in the
case of divergent genes (Bae et al., 2008; Lee et al., 2014). It is
known that the genome of S. cerevisiae is highly compact (an
ORF every 2 kb in average) and less than 6% of the convergent
adjacent genes show a pattern of co-expression. This suggests that
a counter-selection pressure for co-transcribed convergent genes
exists (Dujon, 1996). Prescott and Proudfoot (2002) described a
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drastic effect on the transcription processes of two convergent
genes when intergenic sequences containing genes terminators
were removed. They interpreted this phenomenon by a collision,
in the absence of terminators, between RNA polymerases simul-
taneously transcribing the two genes. These effects were abolished
when the two transcriptional processes were not simultaneous,
confirming the strong TI in the case of simultaneous transcription.
Contrarily to previous studies (Bae et al., 2008; Lee et al., 2014), our
results provide a clear indication that relative positioning of three
contiguous transcription units and their orientations probably
induce TI on a multicopy plasmid. Large TI effects demonstrated
in our design may be related to terminators efficiency, and are
probably accentuated by the absence of extra-space between our
three transcription units.
We show here that the strengths of chosen promoters, as given
by the available literature data, are not systematically conserved
when used for the reconstruction of foreign pathways. TI, ORF
nature, and possibly terminator may also counterbalance the ini-
tially imposed regulation. In strains from set 1, we observed a
factor of 1,000 between CRTI and CRTZ mRNA levels, a surpris-
ing result considering that the expected regulation of mRNA levels
by promoters strengths is supposedly a factor of 10 between the
strongest and the weakest promoters (Sun et al., 2012). Overall, we
propose that combinatorial metabolic libraries [similar to COM-
PACTER method (Du et al., 2012)], associating various promot-
ers/terminators to heterologous genes and varying their positions
is probably a quick and reliable method to generate diversity at the
level of transcription regulation. However, due to possible unex-
pected transcriptional effects, we propose that a systematic analysis
of all heterologous genes mRNA levels should be conducted to
link the desired metabolite production level to the real pattern
of transcription. This may allow researchers to select the best
combination according to the production of the desired molecule.
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